Health Canada approves Paxlovid for high-risk adults
Health Canada has approved Pfizer's Paxlovid for use in adults over 18 who are at risk of severe disease or death from COVID-19.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthHealth Canada approves Paxlovid for high-risk adults
Sign in or subscribeBrowse free archive reportsHealth Canada has approved Pfizer's Paxlovid for use in adults over 18 who are at risk of severe disease or death from COVID-19.